|Articles|December 1, 1997

December 1997
Volume 3
Issue 12

Adverse Drug Reactions: A Review for Healthcare Practitioners

Author(s)Linda R. Young, PharmD, J. Douglas Wurtzbacher, PharmD, Crystal S. Blankenship, PharmD

Download PDF: Adverse Drug Reactions: A Review for Healthcare Practitioners

Articles in this issue

over 28 years ago

Article

Cost Implications of Selective Preoperative Screening in the Care of Candidates for Peripheral Vascular Operations

over 28 years ago

Article

Disease Management Interventions to Improve Outcomes in Congestive Heart Failure

over 28 years ago

Article

Sedating Effects of AM/PM Antihistamine Dosing with Evening Chlorpheniramine and Morning Terfenadine

over 28 years ago

Article

Physicians in Training as Quality Managers: Survival Strategy for Academic Health Centers

over 28 years ago

Article

Gastrointestinal Illness in Managed Care: Healthcare Utilization and Costs

over 28 years ago

Article

Recognition and Treatment of Patients in the Persistent Vegetative State

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Adverse Drug Reactions: A Review for Healthcare Practitioners

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies

FDA Approves Another OTC Naloxone Nasal Spray for Opioid Overdose

United Therapeutics Plans FDA Submission for Inhaled Treprostinil in IPF

Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology

5 Questions Dermatology Patients May Have About Newly-Approved Bemotrizinol